For the best experience on the Abcam website please upgrade to a modern browser such as Google Chrome
We use cookies to make our site as useful as possible.
Our Cookie Policy explains how you can opt-out of the cookies we use.
If you continue without changing your cookie settings, we'll assume you’re happy with this.
Cancer cells employ several immunosuppressive mechanisms to prevent the protective function of the immune system. For example, they can downregulate the expression of tumor antigens on their surface to evade recognition. To suppress immune function, these cells secrete paracrine mediators and suppressive cytokines which operate to inhibit the penetration of T cells into the tumor, inactivate effector T cells, and activate suppressor T cells.
Everything you need to unlock the power of immuno-oncology biomarkers.
Get the full picture for your tumor microenvironment research.
Join Dr George Prendergast as he discusses the future of Immunochemotherapy.
637539907040000000
Protocol
Article